BURLINGTON, Mass.--(BUSINESS WIRE)--ConforMIS, Inc., a privately held company that develops and commercializes minimally invasive medical devices for the treatment of osteoarthritis and joint damage, announced today it received CE Mark approvals for both the iUni™ uni-compartmental resurfacing device and the iJig™ instrument system for use with the iUni on December 3, 2007. The two products were CE Mark approved separately, with both providing regulatory approval for ConforMIS to begin sales of these products throughout the European Union and potentially provide the basis for approval or registration in other countries outside the U.S., including Australia and Canada.
